UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
35 hedge funds and large institutions have $995K invested in Unity Biotechnology in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-5
Holders Change %
-12.5%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
2
Increased
11
Reduced
4
Closed
7
Calls
$31K
Puts
$5K
Net Calls
+$26K
Net Calls Change
-$179K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$58.5K |
| 2 |
HF
HRT Financial
New York
|
$13K |
| 3 |
Morgan Stanley
New York
|
$23.3K |
| 4 |
Renaissance Technologies
New York
|
$37.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$64.2K |
